These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11300963)

  • 21. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?
    Wood E; Tyndall MW; Spittal PM; Li K; Kerr T; Hogg RS; Montaner JS; O'Shaughnessy MV; Schechter MT
    CMAJ; 2001 Aug; 165(4):405-10. PubMed ID: 11531048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
    Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
    Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
    Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of used syringe use and unsafe sex among people who inject drugs in Kumasi, Ghana: an urgent call for a comprehensive harm reduction approach.
    Messersmith LJ; Adjei R; Beard J; Bazzi AR; Earlywine JJ; Darko E; Agyarko-Poku T; Asafo MK; Bempah SA; Adu-Sarkodie Y
    Harm Reduct J; 2021 Jun; 18(1):62. PubMed ID: 34112187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary syringe exchange among users of 23 California syringe exchange programs.
    Lorvick J; Bluthenthal RN; Scott A; Gilbert ML; Riehman KS; Anderson RL; Flynn NM; Kral AH
    Subst Use Misuse; 2006; 41(6-7):865-82. PubMed ID: 16809176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
    Ganju D; Ramesh S; Saggurti N
    Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
    Shaw SY; Shah L; Jolly AM; Wylie JL
    Addiction; 2007 Oct; 102(10):1626-35. PubMed ID: 17854339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The injection of methadone syrup in New South Wales: patterns of use and increased harm after partial banning of injecting equipment.
    Hopwood M; Southgate E; Kippax S; Bammer G; Isaac-Toua G; MacDonald M
    Aust N Z J Public Health; 2003 Oct; 27(5):551-5. PubMed ID: 14651404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies.
    Kral AH; Anderson R; Flynn NM; Bluthenthal RN
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1307-12. PubMed ID: 15385739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
    Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
    J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relative risk of HIV among IDUs not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    AIDS Care; 2009 Aug; 21(8):984-91. PubMed ID: 20024754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'South Asian cocktail'--the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour.
    Ojha SP; Sigdel S; Meyer-Thompson HG; Oechsler H; Verthein U
    Harm Reduct J; 2014 May; 11():17. PubMed ID: 24886095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
    Miller M; Mella I; Moi H; Eskild A
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.
    Garfein RS; Rondinelli A; Barnes RF; Cuevas J; Metzner M; Velasquez M; Rodriguez D; Reilly M; Xing J; Teshale EH
    J Urban Health; 2013 Jun; 90(3):516-28. PubMed ID: 22766605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV incidence among injecting drug users in New York City syringe-exchange programmes.
    Des Jarlais DC; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman SR
    Lancet; 1996 Oct; 348(9033):987-91. PubMed ID: 8855855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange.
    De P; Cox J; Boivin JF; Platt RW; Jolly AM
    J Urban Health; 2008 Jan; 85(1):77-89. PubMed ID: 18038211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.
    Costenbader EC; Zule WA; Coomes CC
    Int J Drug Policy; 2010 Sep; 21(5):425-8. PubMed ID: 20097052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.